Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2020

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Glaucoma Surgery Devices Overview

3 Products under Development
3.1 Glaucoma Surgery Devices - Pipeline Products by Stage of Development
3.2 Glaucoma Surgery Devices - Pipeline Products by Segment
3.3 Glaucoma Surgery Devices - Pipeline Products by Territory
3.4 Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
3.5 Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
3.6 Glaucoma Surgery Devices - Ongoing Clinical Trials

4 Glaucoma Surgery Devices - Pipeline Products under Development by Companies
4.1 Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
4.2 Glaucoma Surgery Devices - Pipeline Products by Stage of Development

5 Glaucoma Surgery Devices Companies and Product Overview
5.1 Alievio Inc Company Overview
5.1.1 Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Allergan Ltd Company Overview
5.2.1 Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Assenti, LLC Company Overview
5.3.1 Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Avisi Technologies LLC Company Overview
5.4.1 Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 Corneat Vision Ltd Company Overview
5.5.1 Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Eye Sonix Company Overview
5.6.1 Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview
5.7 Galaxy Ophthalmics Inc (Inactive) Company Overview
5.7.1 Galaxy Ophthalmics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.8 Geuder AG Company Overview
5.8.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
5.9 Glaukos Corp Company Overview
5.9.1 Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 InnFocus Inc Company Overview
5.10.1 InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 iScience Interventional Inc Company Overview
5.11.1 iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 iSTAR Medical SA Company Overview
5.12.1 iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.13 iVeena Delivery Systems Inc Company Overview
5.13.1 iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Johns Hopkins University Company Overview
5.14.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.15 Kytogenics Pharmaceuticals Inc Company Overview
5.15.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Medtronic Plc Company Overview
5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Meir Medical Center Company Overview
5.17.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.18 Merz Anteis SA Company Overview
5.18.1 Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview
5.19 MicroOptx, Inc. Company Overview
5.19.1 MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.20 Ocumatrx Company Overview
5.20.1 Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview
5.21 OcuTherix Inc Company Overview
5.21.1 OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 OPKO Health Inc Company Overview
5.22.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 OptoLight Vision Technology Company Overview
5.23.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
5.24 Purdue University Company Overview
5.24.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
5.25 Quantel Medical SA Company Overview
5.25.1 Quantel Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.26 Queen's University Company Overview
5.26.1 Queen's University Pipeline Products & Ongoing Clinical Trials Overview
5.27 Sheba Medical Center Company Overview
5.27.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.28 Sight Sciences Inc Company Overview
5.28.1 Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 SOLX Inc Company Overview
5.29.1 SOLX Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Tel Aviv University Company Overview
5.30.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Colorado Company Overview
5.31.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.32 University of Michigan Company Overview
5.32.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.33 Westhouse Medical Services Plc (Inactive) Company Overview
5.33.1 Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

6 Glaucoma Surgery Devices- Recent Developments
6.1 Oct 30, 2020: PolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch + Lomb executive, to its Board of Directors
6.2 Sep 07, 2020: Pomerantz law firm announces the filing of a class action against Staar Surgical Company and certain officers - STAA
6.3 May 13, 2020: OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network enter into strategic laboratory collaboration to deliver operational and diagnostic services
6.4 Apr 13, 2020: STAAR Surgical provides covid-19 business update
6.5 Apr 07, 2020: Alcon provides update on covid-19
6.6 Mar 12, 2020: Ocular Therapeutix reports fourth quarter and year end 2019 financial results and business update
6.7 Mar 10, 2020: Sight Sciences announces publication of first-ever multicenter MIGS study in childhood glaucoma
6.8 Mar 03, 2020: Ocular Therapeutix announces preliminary fourth quarter 2019 net product revenue
6.9 Feb 26, 2020: STAAR Surgical reports fourth quarter and full year 2019 results
6.10 Feb 26, 2020: NanoString Technologies releases fourth quarter and full year 2019 operating results and provides 2020 financial outlook
6.11 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.12 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.13 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.14 Jan 15, 2020: ELT Sight announces scientific advisory board
6.15 Jan 13, 2020: STAAR Surgical reports preliminary fourth quarter net sales growth of 25%
6.16 Dec 18, 2019: STAAR CFO to retire in 2020
6.17 Dec 09, 2019: Sight Sciences appoints Erica Rogers to its Board of Directors
6.18 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Table 2: Glaucoma Surgery Devices - Pipeline Products by Segment
Table 3: Glaucoma Surgery Devices - Pipeline Products by Territory
Table 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Table 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Table 6: Glaucoma Surgery Devices - Ongoing Clinical Trials
Table 7: Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
Table 8: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Table 9: Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Camras Shunt - Product Status
Table 11: Camras Shunt - Product Description
Table 12: Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 13: XEN63 - Product Status
Table 14: XEN63 - Product Description
Table 15: Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Intraocular Pressure Monitoring System - Product Status
Table 17: Intraocular Pressure Monitoring System - Product Description
Table 18: Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 19: VisiPlate - Product Status
Table 20: VisiPlate - Product Description
Table 21: Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: CorNeat eShunt - Product Status
Table 23: CorNeat eShunt - Product Description
Table 24: Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Therapeutic Ultrasound Device - Glaucoma - Product Status
Table 26: Therapeutic Ultrasound Device - Glaucoma - Product Description
Table 27: Galaxy Ophthalmics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Titan Shunt - Product Status
Table 29: Titan Shunt - Product Description
Table 30: Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Microsystem Implant - Product Status
Table 32: Microsystem Implant - Product Description
Table 33: Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 34: iStent Infinite Trabecular Micro-Bypass System - Product Status
Table 35: iStent Infinite Trabecular Micro-Bypass System - Product Description
Table 36: iStent SA Trabecular Micro-Bypass System - Product Status
Table 37: iStent SA Trabecular Micro-Bypass System - Product Description
Table 38: iStent Supra Suprachoroidal Micro-Bypass Stent - Product Status
Table 39: iStent Supra Suprachoroidal Micro-Bypass Stent - Product Description
Table 40: Glaukos Corp - Ongoing Clinical Trials Overview
Table 41: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent
Table 42: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects with Cataract Treated with Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent
Table 43: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 in Conjunction with Cataract Surgery
Table 44: iStent SA Trabecular Micro-Bypass System - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication (Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject)
Table 45: iStent SA Trabecular Micro-Bypass System - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications (One a Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject) and a Postoperative Topical Prostaglandin
Table 46: iStent SA Trabecular Micro-Bypass System - Initial Phase of U.S. IDE Clinical Trial for Standalone Version of iStent inject
Table 47: iStent SA Trabecular Micro-Bypass System - Trabeculectomy with MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors
Table 48: iStent Infinite Trabecular Micro-Bypass System - A Prospective, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-bypass System, Model iS3, in Subjects with Refractory Glaucoma
Table 49: InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: PreserFlo MicroShunt - Product Status

List of Figures
Figure 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Figure 2: Glaucoma Surgery Devices - Pipeline Products by Segment
Figure 3: Glaucoma Surgery Devices - Pipeline Products by Territory
Figure 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Figure 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Glaucoma Surgery Devices - Ongoing Clinical Trials